👤 Han Mo

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
63
Articles
47
Name variants
Also published as: Zengnan Mo, Rou Mo, Chia-Kuei Mo, Xiaohui Mo, Weiliang Mo, Qiaoman Mo, L Mo, Hao-Lin Mo, Shuangyang Mo, Caijing Mo, Zhongxiang Mo, Qingqing Mo, Jun-Ting Mo, Peng-Ying Mo, Saijun Mo, Hui Mo, Jiaxin Mo, Linjian Mo, Fei Mo, Haolin Mo, Hongfang Mo, Min Mo, Shenlong Mo, Xiangang Mo, Xu-ming Mo, Kaiqi Mo, Chao Mo, Xing-Bo Mo, Zhong-cheng Mo, Jiajia Mo, Yulin Mo, Qianxing Mo, Zhuomao Mo, Fengfeng Mo, Dongping Mo, Tingrun Mo, Fang Mo, Xingbo Mo, Juanfen Mo, Xiaofen Mo, Zixin Mo, Biwen Mo, Dan Mo, Min-Hsiang Mo, Jimmy H Mo, Yingli Mo
articles
Si-guo Chen, Ji Xiao, Xie-hong Liu +9 more · 2010 · Acta pharmacologica Sinica · Nature · added 2026-04-24
To determine the effects and potential mechanisms of ibrolipim on ATP-binding membrane cassette transporter A-1 (ABCA1) and ATP-binding membrane cassette transporter G-1 (ABCG1) expression from human Show more
To determine the effects and potential mechanisms of ibrolipim on ATP-binding membrane cassette transporter A-1 (ABCA1) and ATP-binding membrane cassette transporter G-1 (ABCG1) expression from human macrophage foam cells, which may play a critical role in atherogenesis. Human THP-1 cells pre-incubated with ox-LDL served as foam cell models. Specific mRNA was quantified using real-time RT-PCR and protein expression using Western blotting. Cellular cholesterol handling was studied using cholesterol efflux experiments and high performance liquid chromatography assays. Ibrolipim 5 and 50 μmol/L significantly increased cholesterol efflux from THP-1 macrophage-derived foam cells to apoA-I or HDL. Moreover, it upregulated the expression of ABCA1 and ABCG1. In addition, LXRα was also upregulated by the ibrolipim treatment. In addition, LXRα small interfering RNA completely abolished the promotion effect that was induced by ibrolipim. Ibrolipim increased ABCA1 and ABCG1 expression and promoted cholesterol efflux, which was mediated by the LXRα signaling pathway. Show less
no PDF DOI: 10.1038/aps.2010.166
NR1H3
Xin Ma, Yan-wei Hu, Zhong-cheng Mo +6 more · 2009 · Cardiovascular drugs and therapy · Springer · added 2026-04-24
The Niemann-Pick C1 (NPC1) protein regulates the transport of cholesterol from late endosomes/lysosomes to other compartments responsible for maintaining intracellular cholesterol homeostasis. Liver X Show more
The Niemann-Pick C1 (NPC1) protein regulates the transport of cholesterol from late endosomes/lysosomes to other compartments responsible for maintaining intracellular cholesterol homeostasis. Liver X receptors (LXRs) operate as cholesterol sensors which may protect from cholesterol overload by increasing the amount of free cholesterol in the plasma membrane through inducing NPC1 expression. NO-1886 has been proven to be highly effective at increasing liver X receptor alpha expression and promoting cellular cholesterol efflux. In this study, the effects of NO-1886 on NPC1 expression were investigated in THP-1 macrophage-derived foam cells. Results showed that NO-1886 markedly increased expression of NPC1 at both mRNA level and protein level in a dose-dependent and time-dependent manner. Cellular cholesterol content was decreased while cholesterol efflux was increased by NO-1886 treatment. In addition, LXR alpha was also up-regulated by NO-1886 treatment. And LXR alpha small interfering RNA completely abolished the promotion effect which was induced by NO-1886. These results provide evidence that NO-1886 up-regulates expression of NPC1 through LXR alpha pathway in THP-1 macrophage- derived foam cells. Show less
no PDF DOI: 10.1007/s10557-009-6165-8
NR1H3
Xu-ming Mo, En-chun Zhao, Min-sheng Wang +3 more · 2002 · Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation · added 2026-04-24
A flow controlling system for pulsed inhaled nitric oxide has been developed and tested, and here its features and initial animal experiments and clinical applications are described. The physical char Show more
A flow controlling system for pulsed inhaled nitric oxide has been developed and tested, and here its features and initial animal experiments and clinical applications are described. The physical characteristic test indicates that the practical released dose of NO gas is very close to the theoretical flow of NO gas at variant pressures. Animal experiments demonstrate that inhaled NO gas concentration is lower than the concentration of theoretical inhalation, but the variance is not remarkable (p>0.05). When sixteen cases with CHD and PH were chosen to inhale NO gas (15 ppm, 15 min) PAP and PVR of all cases were reduced after inhalation of NO gas from 617 +/-51.3 dyn x s x cm(-5), 54.4+/-13.1 mmHg to 417+/-36.9 dym x s x cm(-5), 33.8+/-12.3 mmHg (PVR, p<0.01; PAP, p<0.01) respectively. When gas inhalation was stopped, these values returned to their base lines after a short period of time. All these show that the pulsed inhaled NO flow controlling instrument in accordance with the requirements of the designing, can be widely used in clinical diagnoses and treatments and will be a new tool offered for the treatments of the patients with PH. Show less
no PDF
DYM